Jain Global’s Arcus Biosciences RCUS Stock Holding History

Jain Global’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,256	Closed	-$207K	–	1466
2025 Q3	$207K	Sell	15,256 -184,707	-92%	-$1.92M	﹤0.01%	894
2025 Q2	$1.63M	Buy	+199,963	New	+$1.71M	0.01%	546

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jain Global's RCUS Position: Q4 2025 in Review

Jain Global sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 15,256 shares — an estimated $207K sold.

Jain Global first reported a position in RCUS in Q2 2025 and held it in 2 quarters. The position peaked at $1.63M in Q2 2025. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

Jain Global reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
Jain Global sold 15,256 Arcus Biosciences shares in Q4 2025, an estimated $207K.
Jain Global first reported a position in Arcus Biosciences in Q2 2025 and held it in 2 quarters.
Jain Global's Arcus Biosciences position peaked at $1.63M in Q2 2025.
209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.